title: Serum and tissue levels of CEA, TPA, CA 125 and CA 15.3 in patients with lung cancer.
abstract: Forty-nine healthy subjects (Group I), 24 patients with benign lung diseases (Group II) and 48 patients surgically treated for lung cancer (Group III): 28 with squamous cell carcinoma (SCC) and 20 with adenocarcinoma (adenoca), were tested for the presence of carcinoembryonic antigen (CEA), tissue polypeptide antigen (TPA), cancer antigen CA 125 and antigen CA 15.3. The four markers were measured in the serum of the patients of the three groups and in the cytosol extract of tumoral and peritumoral tissues of Group III subjects. The mean levels of serum CEA and TPA were significantly higher in squamous cell carcinoma and in adenocarcinoma patients than in normal subjects. In benign lung disease serum CEA was equal and TPA slightly higher than in normal subjects. CA 125 was higher in the serum of patients with malignant diseases compared to normal or benign lung diseases but this difference was not statistically significant. Serum CA 15.3 levels were similar in all subjects studied. CA 125 in squamous cell carcinoma cytosol was much higher than in peritumoral cytosol whereas the other three markers were not significantly different in tumor cytosol or peritumoral cytosol. A direct correlation between serum and cytosol values was observed for CEA, but not for the other markers. The levels of the four markers in serum and cytosol did not correlate with the stage or grade of the tumors.
authors.affiliation: CNR Center of Endocrinology and Experimental Oncology, Faculty of Medicine and Surgery, University Federico II, Napoli, Italy.
authors.forename: V
authors.initials: V
authors.lastname: Macchia
authors.forename: D
authors.initials: D
authors.lastname: Paduano
authors.forename: A
authors.initials: A
authors.lastname: Di Carlo
authors.forename: A
authors.initials: A
authors.lastname: Mariano
authors.forename: C
authors.initials: C
authors.lastname: Cecere
authors.forename: G
authors.initials: G
authors.lastname: Ferrante
mesh_terms: D000230:Adenocarcinoma / Q000097:blood / Q000276:immunology / Q000378:metabolism; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000951:Antigens, Neoplasm / Q000097:blood* / Q000378:metabolism; D015295:Antigens, Tumor-Associated, Carbohydrate / Q000097:blood / Q000378:metabolism; D014408:Biomarkers, Tumor / Q000097:blood* / Q000378:metabolism; D002272:Carcinoembryonic Antigen / Q000097:blood / Q000378:metabolism; D002294:Carcinoma, Squamous Cell / Q000097:blood / Q000276:immunology / Q000378:metabolism; D003600:Cytosol / Q000276:immunology / Q000378:metabolism; D005260:Female; D006801:Humans; D008175:Lung Neoplasms / Q000097:blood* / Q000276:immunology / Q000378:metabolism; D008297:Male; D008875:Middle Aged; D010455:Peptides / Q000097:blood / Q000378:metabolism; D011379:Prognosis; D019396:Tissue Polypeptide Antigen
chemical_list: D000951:Antigens, Neoplasm; D015295:Antigens, Tumor-Associated, Carbohydrate; D014408:Biomarkers, Tumor; D002272:Carcinoembryonic Antigen; D010455:Peptides; D019396:Tissue Polypeptide Antigen